Abstract We evaluated the acceptability and use of macronutrient supplementation among HIV-infected pregnant Ugandan women receiving antiretroviral therapy in a clinical study (NCT 00993031). We first conducted formative research among 56 pregnant and lactating women to select a supplement regimen. Acceptability and use of the supplementation regimen (35 sachets of lipid-based nutrient supplements (LNS) and 4 or 6 kg of instant soy porridge for the household provided monthly) were evaluated among 87 pregnant women. Organoleptic assessments of LNS were favorable. Participants reported consuming LNS a mean of 6.1 days per week, and adherence to recommended consumption behaviors (e.g. frequency, quantity, not sharing) was [80 %. Few women reported negative social consequences of supplementation. The majority of participants also consumed most of the porridge intended for the household. In sum, LNS was acceptable and used regularly. Larger studies to evaluate physical and psychosocial consequences of LNS during pregnancy among HIV-infected women are warranted.
Introduction
HIV-infected pregnant women have elevated macro-and micronutrient requirements due to the metabolic demands of both pregnancy and HIV disease [1] [2] [3] . Nutrient deficiencies, in turn, have demonstrable deleterious health consequences in both pregnant [4] and HIV-infected populations [5, 6] . The observed sequelae of poor nutrition during pregnancy among HIV-infected populations includes a range of adverse maternal, obstetric and infant health outcomes, including a potential increased risk of vertical transmission [7] [8] [9] [10] [11] .
Consistent with this, data from our then ongoing trial among HIV-infected pregnant Ugandan women receiving antiretroviral therapy (NCT00993031, http://clinicaltrials. gov) indicated that both net weight loss during pregnancy and grossly inadequate gestational weight gain (GWG) were common. Further, low GWG (\0.1 kg/week) was Electronic supplementary material The online version of this article (doi:10.1007/s10461-014-0947-0) contains supplementary material, which is available to authorized users. associated with increased risk for low birthweight (LBW), preterm delivery, and composite adverse birth outcomes [11] . Because nutritional status is a major modifiable determinant of both maternal and infant health [12] [13] [14] and poor nutritional status is common among many HIVinfected pregnant women [7] [8] [9] [10] [11] , we sought to offer a supplementation regimen to our pregnant participants that would be appropriate for increasing weight gain.
However, little is known about the implementation or effects of supplementation of HIV-infected pregnant women [15] . First, the majority of nutritional supplementation studies during pregnancy have been conducted among HIV-uninfected populations [16] . Of these, the few studies that have assessed supplement acceptability during pregnancy [17] [18] [19] [20] [21] have revealed great variability. Second, the number of supplementation studies conducted among HIV-infected pregnant women is limited, and all have focused on micronutrients [15] . Indeed, the clinical effects and other benefits of macronutrient supplementation for the general population of people living with HIV (PLHIV) remain largely unknown [22] [23] [24] . There are even fewer data about the effects of macronutrient supplementation on pregnant and lactating women, with a notable exception of the BAN study, which provides important insights into macronutrient supplementation during lactation [25, 26] . Importantly, a recent Cochrane review suggested that there are currently insufficient data to assess the impact of macronutrient interventions on morbidity or mortality among even the general population of PLHIV [27] . Therefore, we set out to determine the perceived needs, acceptability, and use of a macronutrient supplement during pregnancy.
Methods

Setting
This study was nested within a prospective clinical trial in Tororo, Uganda, evaluating malaria outcomes among HIVinfected pregnant women between 12 and 28 weeks gestation who had been randomized to receive a lopinavir/ ritonavir or efavirenz-based combination antiretroviral regimen (NCT00993031, http://clinicaltrials.gov). Women were followed monthly until 1 year postpartum. Briefly, women with HIV-1 infection and a documented pregnancy between 12 and 28 weeks of gestation were eligible for enrollment in the parent clinical trial. All participants received multivitamins containing iron and folic acid, as well as iron supplements, prophylactic mebendazole, an insecticide-treated bed net, and were started on either zidovudine/lamivudine/efavirenz or zidovudine/lamivudine/lopinavir/ritonavir. Women were also started on daily trimethoprim/sulfamethoxazole (TS) if they were not already receiving TS prophylaxis prior to study enrollment. Women were encouraged to breastfeed for 1 year postpartum.
Study Procedures
Formative Study
To understand the perceived nutritional challenges and needs in the community, semi-structured interviews lasting approximately 90 min were conducted with a convenience sample of pregnant (n = 24) and lactating (n = 32) study participants, from June until August 2011. The interview guide was informed by the ecological model of nutrition, in which the individual's biological and psychological needs are understood to both influence and be influenced by multiple social and environmental factors [28, 29] . The last 23 of these participants to be enrolled were asked about the appropriateness and appeal of 8 potential food supplements: millet flour, sesame paste, groundnut paste (peanut butter), roasted termites, mukene (small dried silver cyprinid fish), instant soy porridge both with and without micronutrient Sprinkles added, and Plumpy'Sup. Because Plumpy'Sup, instant soy porridge and micronutrient Sprinkles were unfamiliar to most participants, they were asked to taste them during the interview.
At the end of the interview, participants were asked to assess how much they liked the three supplements they tasted, from 1 (strongly like) to 5 (strongly dislike), and to rank the eight candidate supplements from most (1) to least (8) acceptable. Lastly, participants were asked to explain their rankings, and to describe stigma that they thought could be associated with receiving supplements as well as what the expectations of other household members might be about sharing any supplements received as part of the study. Interviews were conducted in private in the participants' language of choice, primarily Japadhola and Luganda.
Acceptability and Use Study
All pregnant participants who were actively enrolled in the parent study between February and October 2012 were invited to participate in the acceptability and use study, regardless of gestational age. At enrollment into the substudy, participants were asked to consume and rate the organoleptic properties of the lipid-based nutrient supplement (LNS) created for the study. Data were also collected on covariates that were posited to affect or be affected by supplementation, including food insecurity, social support, depression, attitudes towards GWG, stigma, and typical physical activity and diet. All of these interviews were conducted by a locally resident Ugandan woman fluent in Jahadhola and Luganda, who had not previously been involved with the sub-study or parent trial.
Participants then met with a nutritionist individually, for nutritional counseling about appropriate supplement use. Participants were instructed to eat exactly one package of LNS per day, that it should be eaten between meals, i.e. not as a meal replacement, and that it should be eaten only by her, ''taken like any other drug you receive from the clinic or pharmacy''. Instructions were also given on the preparation of soy porridge. Participants were asked to use it to prepare family meals, and to not sell or share it with neighbors or relatives. They were then given a month's supply of both supplements: 35 sachets of LNS, and 4 kg of soy porridge if \7 household members were reported (adults and children were not differentiated) and 6 kg of soy porridge if there were 7 or more in the household.
Participants were asked to return to the clinic every month as part of the parent study activities. At these follow-up visits, they were surveyed about their experiences with the supplements, including consumption patterns, as well as about the above covariates. They then received further nutritional counseling from the study nutritionist and another month's supply of supplement. The nutritionist logged any challenges participants faced.
Food insecurity was assessed using the household food insecurity access scale (HFIAS) [30] and Household Hunger Scale (HHS) [31] . Social support was assessed using the perceived social support scale [32] , which is a modified version of the Duke-UNC Functional Social Support questionnaire [33] . Depression was assessed using the 11 cognitive and affective symptom items on Center for Epidemiologic Studies Depression Scale (CES-D) [34] . In order to limit confounding depression with HIV diseaserelated symptoms, we did not administer somatic depression items because they overlap with HIV-related symptoms [35] . Stigma was measured using the Internalized AIDS-Related Stigma Scale [36] . Reported possession of six household assets were used as a proxy for wealth. Anthropometric data, including maternal height and weight, gestational age, obstetric outcomes and infant birthweight were collected in the parent study, as described elsewhere [11] .
Supplementation stopped after maternal delivery. Within 2 weeks after delivery, participants who had had at least 4 weeks of exposure to the LNS supplement were invited to take part in a semi-structured exit interview about their experiences with supplementation in the study, in which individual-, interpersonal-, and community-level experiences with supplements were explored.
Data Analysis
Qualitative analysis followed the principles and procedures of Grounded Theory [37, 38] . For the semi-structured formative interviews, notes were typed up and then read by three of the authors. Each independently identified themes, and the first author then developed a coding structure based on the list of themes. The transcripts were subsequently reread by two authors, quotes were manually extracted, and frequencies of responses pertinent to each of the themes were tallied. For the exit interviews, conducted among women exposed to at least 1 month of supplement, a similar procedure was followed for developing a coding structure. The transcripts were then coded by two independent coders (CM, AZ) using the qualitative software dedoose (www.dedoose.com).
Quantitative data from the acceptability and use study were analyzed to examine the relationship between LNS supplementation and both psychosocial (depression, food insecurity, social support, stigma) and physiological [anthropometric and obstetric outcomes] constructs. Participants were dichotomized according to their reported supplement consumption: Those who reported consuming one or more LNS packages 6 or 7 days per week on average throughout the study period were considered ''high consumers''; the rest were ''low consumers''. As a proxy for wealth, we used the first two components of a principle component analysis of six household assets, which accounted for 55.7 % of the information contained in the asset holding variables. Women were then categorized as either having ''high'' household assets if they scored above the median for both components, or ''low'' if not.
Continuous variables were compared between ''high'' and ''low'' supplement consumer groups using the Wilcoxon rank sum test, and categorical variables were compared using Fisher's exact test. Baseline comparisons were performed using all women who returned for at least one follow-up visit during the supplement period and whose data were available. Post-supplementation comparisons were restricted to women who had at least two follow-up visits during the supplementation period. For some outcomes, missing data values resulted in slightly smaller sample sizes. Additionally, all anthropometric comparisons were restricted to participants whose first and last followup visits were at least 28 days apart. Changes in outcomes during the supplementation period were calculated as the difference between each participant's last and first measurements. Change in GWG and BMI were calculated by taking the difference between the last and first measurements and dividing it by the number of weeks between the measurements. All analyses were performed using Stata 12.0 (StataCorp).
Ethics
All women gave written informed consent. The study protocol was approved by Cornell University, the Faculty of Medicine's Research and Ethics Committee at Makerere University, the Uganda National Council of Science and Technology, and the Committee on Human Research at the University of California San Francisco.
Results
Formative Study
Formative research revealed that adequate food and good nutritional status during pregnancy and lactation were of major concern to participants. For example, 59 % (33/56) of participants reported difficulties in accessing sufficient food, and 45 % typically ate only 1 or 2 meals per day. This was triangulated by later findings among participants in the parent study that the prevalence of moderate to severe household hunger and moderate to severe household food insecurity access were 47.8 and 76.7 %, respectively [39] .
Further, 73 % (41/56) of participants thought that their current diet had negative consequences for their health: ''I sometimes get stressed when I wake up in the morning and begin thinking where I am going to get food for the family [and] sometimes you may get food that is not enough for the family so you may not even get some to spare for yourself for swallowing your medicine''. Other perceived negative consequences of insufficient diets were exacerbated side effects of anti-retroviral therapy (ART): ''[Eating] helps me to avoid getting dizzy like when I swallow them [ARTs] before eating food.'' ''When I am taking medicine minus eating, I feel like I have no energy.'' Given the difficulties many participants had in acquiring sufficient food, the possibility of receiving supplements during pregnancy was appealing. One-third of the 24 pregnant participants thought that it could help with ''maternal energy'' during pregnancy, and 20.8 % thought that it could help the mother and/or baby. Although 62.5 % of the pregnant participants said they would not share their supplements, 20.8 % said they would not be able to refuse sharing with their children, and 29.1 % said they would like to share at least with their younger children. Ideas suggested for reducing sharing included eating the supplement away from the family (25 %), having other food for the family (16.6 %), and educating the family on the importance of the supplement (12.5 %). Only one pregnant women thought that receiving supplements might cause stigma.
Of the three items that participants would have been unfamiliar with, such that they were offered tastes before actually evaluating their overall likeability (PlumpySup, and instant soy porridge with and without micronutrient Sprinkles), Plumpysup had the highest median likeability score (1) higher than soy porridge alone (3) or with Sprinkles (3). When ranking the overall acceptability of all eight supplements, however, instant soy porridge with Sprinkles was ranked as the most acceptable (median rank 2), together with millet flour (median rank 2) (Online supplementary Table 1 ). Roasted termites were the least acceptable.
Acceptability and Use Study
We chose to supplement pregnant participants with nonfortified LNS in individual sachets. (Nutritional content described in online supplementary Table 2 ). This decision was informed by participants' ranking of likeability (median rank 1) and overall acceptability (median rank 5, Online supplementary Table 1 ), as well as the study needs to (1) standardize quality and quantity of supplement consumed, (2) minimize sharing, (3) deliver a macronutrient-dense food low in micronutrients such that the parent study protocol of provision of micronutrient tablets would not need to be altered, and (4) reduce substitution of family foods with the study supplement. Supplements were manufactured by Nutriset (Malaunay, France) and flown to Uganda. The cost to purchase 1 month's supply of LNS was $24.62, ($12.45 for the product, $12.17 for shipping).
We also provided a supplement for other household members, to minimize sharing of LNS sachets. We selected instant soy porridge based on its acceptability (median rank 2.5), short preparation time, the variety of ways of consuming it, and ease of sharing amongst many. Instant soy porridge cost $1.50/kg, such that the cost of supplement per month was either $6 or $9 USD.
Study Population
Eighty-eight women were actively enrolled in the parent study during the period of eligibility and were thus invited to participate in the acceptability and use study. Eightyseven women agreed (one woman was allergic to peanuts) and participated in the enrollment visit during which organoleptic properties of LNS were evaluated. Of these, 87.5 % (76/87) returned for at least one follow-up visit during which supplement use was reported on and data were collected on a number of physiological and psychosocial aspects; data were lost from one individual (P2-0534). Ninety-six percent of those eligible (73/76) participated in the qualitative ''exit interview''. All study attrition was due to delivery; no woman withdrew consent for the nutrition sub-study.
Acceptability of LNS
Participants (n = 87) had a very favorable opinion of the study LNS at their initial encounter. The median score for taste, smell, texture, packaging, and ''overall liking'' of the LNS supplement was 1 (out of 5, ''strongly like''). Further, a rating of 1 or 2 (''strongly like or like'') was given by the majority of participants for taste (87.5 %), smell (94.3 %), texture (96.9 %), packaging (100 %), and ''overall evaluation'' (96.9 %). In terms of women's assessment of the quantity of LNS in one sachet, 63.6 % felt it was an appropriate amount, while 21.6 % felt it was too much and 14.8 % thought it was too little.
Women reiterated the acceptability of the LNS during the postpartum ''exit interviews''. The majority of participants (92 %) reported that they enjoyed eating LNS. Of those 67 women, (69 %) spontaneously mentioned that they liked the taste, which many compared to groundnuts; 47.8 % mentioned the smell, frequently described as ''sweet'' (which can mean both sugary and pleasant); 18 % appreciated its nutritional value; and 9 % liked that it required no preparation.
The biggest objection to LNS was that it caused nausea and vomiting. This was reported by 14.5 % (11/76) of participants at the first follow-up visit, 7.6 % (5/66) at subsequent follow-up visits, and 13.7 % (10/73) of participants at exit interviews. This was primarily attributed to the supplements being overly sweet. However, eight women who initially disliked the supplement (primarily because it caused nausea and vomiting) grew to like it after receiving counseling on strategies for diminishing nausea associated with its consumption, including eating small amount of LNS throughout the day and drinking warm water with it. Five women who initially liked the supplement reported growing to dislike it, primarily because they found it grew too sweet over time. These data are corroborated by counseling logs that indicate that the most common counseling issues included LNS causing gastrointestinal distress and dislike of its taste or smell (Table 1) .
At the completion of participation in the supplementation sub-study, the majority of participants thought the purpose of LNS was to improve maternal health (41.1 %), infant health (31.5 %), the health of people with HIV (21.9 %), or the health of pregnant women (10.9 %). Four women (5.5 %) initially thought it could be harmful, because it contained HIV medicine (which could hurt others if they consumed it) (n = 2), because it would cause her to vomit her HIV medicine (n = 1), or because it was meant to hurt her directly (n = 1). ''At first I thought that the food was meant to kill me because I have HIV/AIDS, but later on I had a second thought that I am mature, I have done nothing bad, I am innocent, and I have not hurt anybody. I think this is love and care.''
Use of LNS
We assessed adherence to LNS consumption messages by inquiring about frequency and quantity of supplement consumed, if timing coincided with meals (meal replacement), and if supplement was shared (Table 2) . By most measures, reported adherence to counseling messages was high, and improved at subsequent visits. In terms of frequency, LNS was consumed approximately 6 days per week. At the first follow-up visit, 70.1 % reported consuming it the prior day. The most common reasons for not consuming LNS during the prior day was that there was none left (26.0 %) and that it caused nausea or vomiting (14.3 %). At subsequent follow-up visits, 79.9 % of women reported using it the prior day, and the proportion not taking it because they had none left or were experiencing nausea and vomiting dropped to (7.6 %) for both reasons.
In terms of quantity of LNS consumed, the majority of participants typically consumed the entire sachet (83.1 % at initial follow-up, 93.1 % at subsequent visits) and tended to do so right after opening (81.8, 93.6 %, Table 2 ). Some of the lowest adherence was reported for consumption of exactly one sachet in the prior 2 days; this was likely due to low supplies of LNS by the end of the month. Some of the best adherence to supplement use messaging was seen with respect to replacement of other meals with LNS. Women did not report eating LNS with meals (96.1 % at initial followup, 96.6 % at subsequent follow-up visits) or mixing it with other household foods (84.4 % and 96.0 %, subsequently). Reported sharing was minimal; only 15.6 and 4.0 % of women reported actively sharing LNS on first and subsequent clinic visits respectively (Table 2) . At exit interviews, the majority of participants (84.9 %) also reported not feeling compelled to share their LNS with household members. Women attributed their ability to not share by explaining that they were following instructions from the clinic (58.9 %), or that the supplement was meant only for pregnant (15.1 %) or HIV-infected people (12.3 %), or because soy porridge was available for others (12.3 %). Although most women did not feel they needed to share the supplement, 26.0 % reported experiencing theft of LNS. Counseling logs provided triangulation that LNS was sometimes stolen or lost, contributing to low supplies by the end of the month (Table 2) .
Difficulties caused by LNS within the household were reported by 41.1 % of participants at the exit interviews. This was most commonly due to their children wanting to eat the LNS (30.1 %), theft of supplement (26.0 %), envy of supplement (4.1 %), and household members ''saying bad things'' (4.1 %).
Approximately half of the participants (n = 40) reported that people outside their household knew they were using LNS. Of these, women experienced community responses that included curiosity (62.5 %), association with HIV-disease (35.0 %), and a desire to obtain it for themselves (32.5 %). Three women mentioned stigma associated with LNS. For example, one woman's husband did not want LNS in the house for fear that people would know they were both HIV-positive.
Overall, 80 % of women were ''high consumers'', i.e. they reported consuming a mean of at least 1 package per day, 6 or more days per week, throughout the entire supplementation period. At baseline, high consumers had approximately two more residents in their households, were more likely to have disclosed their HIV status, and scored approximately 6 points higher on the HFIAS scale, i.e. lived in households with greater food insecurity ( Table 3) .
Impact of LNS
There were no statistically significant differences in maternal or infant outcomes by reported supplement consumption, including for changes in maternal depression, exertion, household food insecurity, or maternal or infant anthropometry (Table 4) ; the study was not powered to detect these differences. However, trends were in the anticipated direction. For example, women who were high consumers gained 100 g/week more weight than low consumers. Further, infants born to mothers who were high supplement consumers were 1.0 cm longer and a smaller proportion were LBW (9.1 vs. 21.4 %). Infants born to nulliparous and multiparous high consumers weighed 176 and 102 g more at birth, respectively. Lastly, high consumers became less depressed over the course of pregnancy than low consumers (-2.0 change vs. -1.8 change in CESD score), and high consumers scored 0.7 points higher on the HFIAS scale.
Acceptability and Use of Household Food Ration
In exit interviews, 98.6 % of women found the soy porridge to be enjoyable, spontaneously attributing their enjoyment to the taste (75.3 %) which many described ''like fried soya''; the smell, ''like soya flour'' (41.1 %); the nutritional value (21.9 %); and the texture when mixed with other foods (8.2 %). Of note, some of the participants who found the soy porridge to be enjoyable disliked the smell (8.2 %) or thought it caused gastrointestinal distress (2.7 %). One woman initially liked it, but later came to dislike it, while three who initially disliked it (all because of the smell) came to like it. The quantity of soy porridge seemed sufficient; the majority (79 % at initial follow-up, 87.5 % subsequently) reported that ''a little'' or ''none'' remained at the end of the month. Those whom had finished all of the porridge had done so a mean (SD) of 5 (3) days before the clinic visit. In monthly interviews, participants reported that the household food ration was consumed by both children (94 % at first follow-up, 97 % subsequently) and adults (96 and 98 % subsequently) that lived in their household. Surprisingly, study participants seemed to consume the bulk of the soy porridge meant for household members. The majority of women (75 %, at first follow up, 88 % subsequently) reported that they ate ''most'' of the soy porridge and that the majority (67.5 %) of family members ate only ''some''.
As for use outside the household, women reported it being consumed by children (52 % at first follow-up, 66 % subsequently) and adults (40, 62 % subsequently) that lived elsewhere. The amounts shared were small; of those who shared, the majority (91 % at first follow-up, 99 % subsequently) described the quantity as ''a little''. The nonhousehold members with whom the soy porridge was most commonly shared were neighbors (49.3 %) (n = 36 of 73), in-laws (16.4 %), neighbor's children (12.3 %), and others (9.6 %).
Some women spontaneously offered what they thought the purpose of soy porridge was during the exit interviews. Twelve thought it was to help with HIV or ART consumption, 4 thought the soy porridge was for the health of their baby, and 2 thought it was HIV medicine. Women reported that community members thought that the soy porridge was for maternal health (reported by nine participants), to help with pregnancy (n = 8), for providing energy (n = 6), and for the baby's health (n = 2).
In exit interviews, ten women reported that the consequences of receiving the soy porridge were that they felt ''special'' or ''good'', e.g. ''I was thinking about how [they] love me to give this good food to help me during pregnancy,'' and ''I became happy because I had what [sic] to eat''.
As for intra-household consequences, at exit interviews, 82.2 % of participants said the receipt of soy porridge caused no problems. Of those 13 whom experienced problems, seven reported household tension (including envy, name calling, strained relations) and 2 reported theft. Four women spontaneously mentioned positive household impact: improved relationships with their husbands (n = 3), and ''peacefulness'' (n = 1) because the children no longer cried from hunger: ''Before there was no peace because of starvation''. As for consequences of soy outside the home, 74.0 % (54/72) of participants reported that people outside of their household knew that they had received soy porridge. Women reported that community members were curious 48.1 % (26/54), wanted some porridge (33.3 %), or thought it was associated with HIV (27.8 %). For 13 participants, soy porridge caused social problems including strained relationships (n = 7), anger and name calling (n = 7), and ''too much inquisitiveness'' (n = 2). Three women feared that receiving soy porridge supplement would flag them as HIV-infected. Only two women mentioned how relationships with people outside the home changed for the better, namely because they could share with neighbors or visitors.
Discussion
In this first study of macronutrient supplementation of pregnant, HIV-infected women, both LNS and instant soy porridge were regarded favorably and used regularly. Overall, the vast majority of participants enjoyed consuming LNS both at their initial encounter and at the end of the study, citing its positive taste, sweet smell, and ease of preparation. Participants also reported adhering to guidelines for supplement use: the majority (80 %) of participants consumed the entire sachet and ate it at least 6 days a week. Surprisingly, a large proportion of instant soy porridge, which was provided with the intention to reduce household use of the LNS, was consumed by pregnant study participants.
The acceptability of LNS among adult populations has been studied in 4 other countries, all in sub-Saharan Africa [17, [40] [41] [42] [43] [44] [45] OR (Table 5 ). The approaches to developing a supplementation regimen, the regimen itself, period of follow-up and assessment of acceptability and use have varied widely, making comparisons difficult. In broad strokes, however, it is possible to say that both the acceptability and use of LNS in our study compares favorably to other studies. For example, in Ghana, 96 % of the 23 pregnant and lactating participants reported that they either liked the peanut-based LNS ''a little'' or ''a lot'' after a 14 day trial [17] . In our study, 100 % of participants rated all organoleptic characteristics as ''liked'' or ''strongly liked'' at the first assessment, and 92 % reported liking LNS at the exit interview.
Reported use of the supplement in our study (93 % typically consumed entire sachet daily) was similar to or greater than in other LNS studies, even with our longer study follow-up (Table 5 ). In Malawi, 92.4 % of participants reported consuming the recommended amount (140 g) the day prior to clinical visit [26] , while in Ethiopia, 74 % reported eating the recommended portion [42] . In Ghana, 96 % of participants reported consuming the recommended 20 g ''every time'' [17] . Many of the issues with LNS observed in this study are also similar to those of other LNS studies. For example, pregnant and lactating women of unknown HIV status in Ghana [17] and HIV-infected adults in Ethiopia [46] initially reported the sweetness of LNS to cause nausea and vomiting. A less sweet-tasting formulation should likely be considered for future uses. LNS was experienced as stigmatizing by only three of our study participants; the stigmatizing connotations of LNS were also observed, but not quantified, in Kenya [41] and Ethiopia [46] . Our participants' (mis)perceptions of LNS as a drug or medicine occurred less frequently than in the Kenyan and Ethiopian studies [41, 46] .
Reported sharing of LNS was low (15.6 % on first follow-up visit, 4.0 % subsequently), but approximately half of women reported that soy porridge had been shared with both adults and children living outside of the household. Sharing of LNS has also been reported in studies in Ethiopia [46] and Malawi [43] . Wherever food sharing is a common practice and even a cultural expectation, as it is in much of sub-Saharan Africa, it is often difficult for participants to not share their supplement, especially with their children. It was for this reason that we provided soy porridge for the household. Only one other LNS study implemented a means of reducing sharing, and its consumption by the target patient was not measured [26] . It was surprising in our study that participants consumed ''the majority'' of the soy porridge that had been intended for the household, and that only a small proportion of women (12.3 %) attributed not sharing their LNS to the provision of soy porridge. This suggests that the importance of a household supplement may need to be reconsidered.
Although the study was not powered to detect differences in physiological or psychosocial outcomes of interest, we measured a number of characteristics that could possibly be influenced by supplementation for future study planning (Table 5) . Although most differences were not significant, the values were trending in the expected direction, suggesting a positive impact would emerge in a larger study sample. They also resembled impacts of LNS supplementation observed in a much larger study of LNS use among 491 Ghanaian pregnant women of unknown HIV status [40] . There, the receipt of 20 g/d of LNS during pregnancy was associated with an increase of 0.4 cm in birth length compared to non-LNS intervention groups (vs. 1.0 cm in our study) and among primiparous women, infants weighed 200 g more at birth (vs. 176.4 g more in our study). The greater length and weight at birth of infants whose mothers were ''high'' consumers of LNS is biologically significant, and, if replicable at a larger scale, such that statistical significance could be shown, is a finding that could motivate policymakers to see the value of supplementation during pregnancy.
Strengths of this study include a formative phase for determining perceived nutritional needs and an appropriate supplementation regimen; a mixed-methods approach to assessing acceptability and use that included survey data complemented by data from in-depth interviews and counseling logs; inquiry into both the physiological and psychosocial consequences of supplementation for the individual and within the household and community; and the inclusion of a supplement for household members to reduce sharing. The study would have been strengthened by a larger study sample size, but logistics (e.g. LNS delayed in Ugandan customs, new quality control procedures for LNS at Nutriset) precluded this. The measurement of women's intake of soy porridge would have been beneficial for understanding the impact of the intervention, as would better elucidation of why women consumed the majority of the household supplement. Lastly, more intense exploration of reasons for low and high consumption of LNS would help to understand the differential exposure to LNS, especially probing about the role of household size and disclosure (cf. Table 4 ). However, at the time of the exit interview, data about amount of LNS consumed were not available.
In sum, this study contributes to the discussion about appropriate nutritional support for PLHIV because it is the first to present acceptability and use data on macronutrient supplementation of HIV-infected pregnant women. Such information is important because although LNS and other supplements are currently provided to pregnant women as part of a number of programs, including Food by Prescription [22, 47] , their actual use and impact are almost entirely unknown. Our findings here suggest that the plausibility of positive health impacts of supplementation during pregnancy is high and negative psychosocial or physical health consequences seems low, but that further larger studies are needed to determine the health and behavioral impacts, cost-effectiveness, scalability, and sustainability of various supplementation regimens.
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